(Q38082090)

English

Pharmacology of metabotropic glutamate receptor allosteric modulators: structural basis and therapeutic potential for CNS disorders

scientific article published on January 2013

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

28 August 2017

Pharmacology of metabotropic glutamate receptor allosteric modulators: structural basis and therapeutic potential for CNS disorders (English)

1 reference

stated in

Europe PubMed Central

28 August 2017

1 reference

Karen J Gregory

1

0 references

Colleen M. Niswender

series ordinal

3

object named as

Colleen M Niswender

1 reference

stated in

Europe PubMed Central

28 August 2017

Meredith J Noetzel

2

1 reference

stated in

Europe PubMed Central

28 August 2017

1 January 2013

1 reference

stated in

Europe PubMed Central

28 August 2017

Progress in Molecular Biology and Translational Science

1 reference

stated in

Europe PubMed Central

28 August 2017

115

1 reference

stated in

Europe PubMed Central

28 August 2017

61-121

1 reference

stated in

Europe PubMed Central

28 August 2017

Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways.

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1046/J.1471-4159.2001.00435.X

Identifiers

DOI

10.1016/B978-0-12-394587-7.00002-6

1 reference

stated in

Europe PubMed Central

28 August 2017

1 reference

Europe PubMed Central

PubMed ID

23415092

retrieved

28 August 2017

(Q38082090)

Pharmacology of metabotropic glutamate receptor allosteric modulators: structural basis and therapeutic potential for CNS disorders

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)